Opportunities for improving the efficiency of paediatric HIV treatment programmes.

Opportunities for improving the efficiency of paediatric HIV treatment programmes.

<strong>Objectives:</strong> To conduct two economic analyses addressing whether to: routinely monitor HIV-infected children on antiretroviral therapy (ART) clinically or with laboratory tests; continue or stop cotrimoxazole prophylaxis when children become stabilized on ART. <strong&...

Полное описание

Библиографические подробности
Главные авторы:	Revill, P, Walker, S, Mabugu, T, Nathoo, K, Mugyenyi, P, Kekitinwa, A, Munderi, P, Bwakura-Dangarembizi, M, Musiime, V, Bakeera-Kitaka, S, Nahirya-Ntege, P, Walker, A, Sculpher, M, Gibb, D
Формат:	Journal article
Язык:	English
Опубликовано:	Lippincott, Williams and Wilkins 2015

Схожие документы

Tuberculosis incidence is high in HIV-infected African children but is reduced by co-trimoxazole and time on antiretroviral therapy.
по: Crook, A, и др.
Опубликовано: (2016)

A randomized trial of prolonged co-trimoxazole in HIV-infected children in Africa.
по: Bwakura-Dangarembizi, M, и др.
Опубликовано: (2014)

Routine versus clinically driven laboratory monitoring and first-line antiretroviral therapy strategies in African children with HIV (ARROW): a 5-year open-label randomised factorial trial.
по: Kekitiinwa, A, и др.
Опубликовано: (2013)

Pubertal development in HIV-infected African children on first-line antiretroviral therapy.
по: Szubert, A, и др.
Опубликовано: (2015)

Prevalence of lipodystrophy and metabolic abnormalities in HIV-infected African children after 3 years on first-line antiretroviral therapy.
по: Bwakura-Dangarembizi, M, и др.
Опубликовано: (2015)

Mortality in the year following antiretroviral therapy initiation in HIV-infected adults and children in Uganda and Zimbabwe.
по: Walker, A, и др.
Опубликовано: (2012)

Pharmacokinetics of zidovudine dosed twice daily according to World Health Organization weight bands in Ugandan HIV-infected children.
по: Fillekes, Q, и др.
Опубликовано: (2014)

Single-dose nevirapine exposure does not affect response to antiretroviral therapy in HIV-infected African children aged below 3 years.
по: Musoke, P, и др.
Опубликовано: (2015)

Inflammatory biomarkers in HIV-infected children hospitalized for severe malnutrition in Uganda and Zimbabwe
по: Prendergast, A, и др.
Опубликовано: (2019)

Virological response and resistance among HIV-infected children receiving long-term antiretroviral therapy without virological monitoring in Uganda and Zimbabwe: Observational analyses within the randomised ARROW trial
по: Szubert, A, и др.
Опубликовано: (2017)

Pharmacokinetics of antiretroviral drug varies with formulation in the target population of children with HIV-1.
по: Kasirye, P, и др.
Опубликовано: (2012)

The cost-effectiveness of prophylaxis strategies for individuals with advanced HIV starting treatment in Africa
по: Walker, SM, и др.
Опубликовано: (2020)

Reduced bacterial skin infections in HIV-infected African children randomized to long-term cotrimoxazole prophylaxis
по: Prendergast, A, и др.
Опубликовано: (2016)

Predicting patterns of long-term CD4 reconstitution in HIV-infected children starting antiretroviral therapy in sub-Saharan Africa: a cohort-based modelling study.
по: Picat, M, и др.
Опубликовано: (2013)

DART and laboratory monitoring of HIV treatment Reply
по: Walker, A, и др.
Опубликовано: (2010)

Pharmacokinetics and acceptability of once- versus twice-daily lamivudine and abacavir in HIV type-1-infected Ugandan children in the ARROW Trial.
по: Musiime, V, и др.
Опубликовано: (2010)

Marginal structural models for repeated measures where intercept and slope are correlated: an application exploring the benefit of nutritional supplements on weight gain in HIV-infected children initiating antiretroviral therapy
по: Farmer, R, и др.
Опубликовано: (2020)

Baseline inflammatory biomarkers identify subgroups of HIV-infected African children with differing responses to antiretroviral therapy
по: Prendergast, A, и др.
Опубликовано: (2016)

Enhanced prophylaxis with antiretroviral therapy for advanced HIV in Africa
по: Hakim, J, и др.
Опубликовано: (2017)

Virologic response to first-line efavirenz- or nevirapine-based anti-retroviral therapy in HIV-infected African children
по: Kekitiinwa, A, и др.
Опубликовано: (2017)

The impact of viraemia on inflammatory biomarkers and CD4 cell subpopulations in HIV-infected children in sub-Saharan Africa
по: Prendergast, AJ, и др.
Опубликовано: (2021)

Virologic response to first-line efavirenz- or nevirapine-based antiretroviral therapy in HIV-infected African children
по: Kekitiinwa, A, и др.
Опубликовано: (2017)

Virological response and resistance among HIV-infected children receiving long-term antiretroviral therapy without virological monitoring in Uganda and Zimbabwe: Observational analyses within the randomised ARROW trial.
по: Alexander J Szubert, и др.
Опубликовано: (2017-11-01)

Nevirapine clearance from plasma in African adults stopping therapy: a pharmacokinetic substudy.
по: Kikaire, B, и др.
Опубликовано: (2007)

Utilization of “prevention of mother-to-child transmission” of HIV services by adolescent and young mothers in Mulago Hospital, Uganda
по: Mariama Mustapha, и др.
Опубликовано: (2018-11-01)

Marginal structural models for repeated measures where intercept and slope are correlated: An application exploring the benefit of nutritional supplements on weight gain in HIV-infected children initiating antiretroviral therapy.
по: Ruth E Farmer, и др.
Опубликовано: (2020-01-01)

Nevirapine/zidovudine/lamivudine has superior immunological and virological responses not reflected in clinical outcomes in a 48-week randomized comparison with abacavir/zidovudine/lamivudine in HIV-infected Ugandan adults with low CD4 cell counts.
по: Munderi, P, и др.
Опубликовано: (2010)

Effect of handrubbing using locally-manufactured alcohol-based handrubs in paediatric wards in Harare, Zimbabwe
по: Muchaneta Gudza-Mugabe, и др.
Опубликовано: (2017-01-01)

A single CD4 test with 250 cells/mm3 threshold predicts viral suppression in HIV-infected adults failing first-line therapy by clinical criteria
по: Gilks, C, и др.
Опубликовано: (2013)

Biomarkers of mortality in adults and adolescents with advanced HIV in sub-Saharan Africa
по: Riitho, V, и др.
Опубликовано: (2024)

Defeating Paediatric Tuberculous Meningitis: Applying the WHO “Defeating Meningitis by 2030: Global Roadmap”
по: Robindra Basu Roy, и др.
Опубликовано: (2021-04-01)

Once- versus twice-daily abacavir and lamivudine in African children: the randomised controlled ARROW Trial
по: Musiime, V, и др.
Опубликовано: (2016)

Severe renal dysfunction and risk factors associated with renal impairment in HIV-infected adults in Africa initiating antiretroviral therapy.
по: Reid, A, и др.
Опубликовано: (2008)

Ethical and legal constraints to children’s participation in research in Zimbabwe: experiences from the multicenter pediatric HIV ARROW trial
по: Bwakura-Dangarembizi Mutsa, и др.
Опубликовано: (2012-07-01)

Effect of ready-to-use supplementary food on mortality in severely immunocompromised HIV-infected individuals in Africa initiating antiretroviral therapy (REALITY): an open-label, parallel-group, randomised controlled trial
по: Mallewa, J, и др.
Опубликовано: (2018)

Late presentation with HIV in Africa: phenotypes, risk and risk stratification in the REALITY trial
по: Siika, A, и др.
Опубликовано: (2018)

Daily co-trimoxazole prophylaxis in severely immunosuppressed HIV-infected adults in Africa started on combination antiretroviral therapy: an observational analysis of the DART cohort.
по: Walker, A, и др.
Опубликовано: (2010)

Response to highly active antiretroviral therapy varies with age: the UK and Ireland Collaborative HIV Paediatric Study.
по: Walker, A, и др.
Опубликовано: (2004)

Paediatric surgery in Uganda: current challenges and opportunities
по: Alberti, P, и др.
Опубликовано: (2024)

Pediatric underdosing of efavirenz: a pharmacokinetic study in Uganda.
по: Fillekes, Q, и др.
Опубликовано: (2011)